Manar Moustafa
University of Sheffield
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Manar Moustafa.
Journal of Investigative Dermatology | 2009
Michael J. Cork; Simon G. Danby; Yiannis Vasilopoulos; Jonathan Hadgraft; Majella E. Lane; Manar Moustafa; Richard H. Guy; Alice Macgowan; Rachid Tazi-Ahnini; Simon J. Ward
Atopic dermatitis (AD) is a multifactorial, heterogenous disease that arises as a result of the interaction between both environmental and genetic factors. Changes in at least three groups of genes encoding structural proteins, epidermal proteases, and protease inhibitors predispose to a defective epidermal barrier and increase the risk of developing AD. Loss-of-function mutations found within the FLG gene encoding the structural protein, filaggrin, represent the most significant genetic factor predisposing to AD identified to date. Enhanced protease activity and decreased synthesis of the lipid lamellae lead to exacerbated breakdown of the epidermal barrier. Environmental factors, including the use of soap and detergents, exacerbate epidermal barrier breakdown, attributed to the elevation of stratum corneum pH. A sustained increase in pH enhances the activity of degradatory proteases and decreases the activity of the lipid synthesis enzymes. The strong association between both genetic barrier defects and environmental insults to the barrier with AD suggests that epidermal barrier dysfunction is a primary event in the development of this disease. Our understanding of gene-environment interactions should lead to a better use of some topical products, avoidance of others, and the increased use and development of products that can repair the skin barrier.
Regenerative Medicine | 2007
Manar Moustafa; Anthony J. Bullock; Fionuala M Creagh; Simon Heller; William Jeffcoate; Frances L. Game; Carol Amery; Soloman Tesfaye; Zoe Ince; David Haddow; Sheila MacNeil
AIM To compare the rate of healing of diabetic neuropathic ulcers using cultured autologous keratinocytes delivered on chemically defined transfer discs (Myskin) (active treatment) versus healing obtained with cell-free discs (placebo). MATERIALS AND METHODS After a 4-week lead-in period patients (randomly assigned) received active or placebo treatments weekly for 6 weeks. All patients then received active treatments for a maximum of 12 treatments where required. Altogether, 16 patients with a total of 21 ulcers resistant to conventional therapy were recruited from four specialist diabetic centers in three cities. RESULTS All 21 ulcers were treated and of these ten healed and eight improved, with two failing to respond (one ulcer was lost due to autoamputation). For analysis according to the study criteria, however, only the 12 patients with 12 index ulcers who completed treatment protocols were eligible - five in the placebo group and seven in the active group. Of these, five ulcers healed completely and seven were reduced by more than 50%. Complete healing took a median of ten active applications. CONCLUSIONS Repeated regular applications of the patients keratinocytes, delivered on the carrier dressing, initiated wound healing in ulcers resistant to conventional therapy, with 18 out of 21 ulcers responding. The healing observed did not appear attributable to patient recruitment or the cell-free carrier dressing but to the delivery of the cultured cells.
Contact Dermatitis | 2011
Manar Moustafa; Catherine R. Holden; Preeti N. Athavale; Michael J. Cork; Andrew G. Messenger; David J. Gawkrodger
Background. Allergic contact dermatitis in children is less recognized than in adults. However, recently, allergic contact dermatitis has started to attract more interest as a cause of or contributor to eczema in children, and patch testing has been gaining in recognition as a useful diagnostic tool in this group.
The Journal of Allergy and Clinical Immunology | 2016
Lujain H. Albenali; Simon G. Danby; Manar Moustafa; Kirsty Brown; John Chittock; Fiona Shackley; Michael J. Cork
In this study, Vitamin D supplementation results in improved clinical severity of atopic dermatitis and increased skin surface LL-37 levels, analyzed by a novel, non-invasive method. Vitamin D supplementation could be a therapeutic option in AD.
The Journal of Allergy and Clinical Immunology | 2006
Michael J. Cork; Darren Robinson; Yiannis Vasilopoulos; Adam Ferguson; Manar Moustafa; Alice Macgowan; Gordon W. Duff; Simon J. Ward; Rachid Tazi-Ahnini
Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association | 2005
Michael J. Cork; Darren Robinson; Yiannis Vasilopoulos; Adam Ferguson; Manar Moustafa; Mac Gowan A; Simon J. Ward; Rachid Tazi-Ahnini
Archive | 2007
Michael J. Cork; Jibu Varghese; J Hadcraft; Majella E. Lane; Adam Ferguson; Manar Moustafa; Richard H. Guy; Simon J. Ward
Archive | 2008
Michael J. Cork; Simon G. Danby; Yiannis Vasilopoulos; Manar Moustafa; Alice Macgowan; Jibu Varghese; Gordon Duff; Rachid Tazi-Ahnini; Simon Ward
Drug Discovery Today: Disease Mechanisms | 2008
Michael J. Cork; Simon G. Danby; Yiannis Vasilopoulos; Manar Moustafa; Alice Macgowan; Jibu Varghese; Gordon W. Duff; Rachid Tazi-Ahnini; Simon J. Ward
Archive | 2009
Michael J. Cork; Manar Moustafa; Simon G. Danby; Yiannis Vasilopoulos; Rachid Tazi-Ahnini; Simon Ward; Jonathan Hadgraft; Majella E. Lane; Richard H. Guy; Alice Macgowan